Olympiad Research’s GoHealth GOCO Stock Holding History

Olympiad Research’s Portfolio GOCO Stock Details GOCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,082	Closed	-$182K	–	276
2021 Q2	$182K	Sell	1,082 -90	-8%	-$15.8K	0.06%	236
2021 Q1	$205K	Buy	+1,172	New	+$236K	0.09%	159

Other funds holding GOCO

Centerbridge Partners New York $61.1M AUM 3.67% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

GCM

Glendon Capital Management Santa Monica, California $805M AUM 17.91% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Olympiad Research's GOCO Position: Q3 2021 in Review

Olympiad Research sold out of GoHealth (GOCO) in Q3 2021, closing a stake of 1,082 shares — an estimated $182K sold.

Olympiad Research first reported a position in GOCO in Q1 2021 and held it in 2 quarters. The position peaked at $205K in Q1 2021. 130 funds tracked by Wall St. Rank hold GOCO as of Q3 2021.

Olympiad Research reported no remaining GoHealth position as of Q3 2021 after selling out during the quarter.
Olympiad Research sold 1,082 GoHealth shares in Q3 2021, an estimated $182K.
Olympiad Research first reported a position in GoHealth in Q1 2021 and held it in 2 quarters.
Olympiad Research's GoHealth position peaked at $205K in Q1 2021.
130 funds tracked by Wall St. Rank held GoHealth as of Q3 2021.

Based on Olympiad Research's 13F filing for Q3 2021, filed 9 Nov 2021.